Ketamine: A Promising Novel Therapy for Anxiety and PTSD
Ketamine was originally approved by the FDA as an anesthetic, but is increasingly being used to treat mood disorders such as treatment-resistant depression, anxiety disorders, and PTSD.
Anxiety
Systematic Review of Pharmacotherapy for Generalized Anxiety Disorder Highlights Efficacious Options
Although there are a number of effective treatment choices available for generalized anxiety disorder, venlafaxine, pregabalin, escitalopram, and duloxetine appear to be first-line choices.
Anxiety, Depression More Likely for Adults With Atopic Dermatitis
Atopic dermatitis (AD) is associated with increased depression and anxiety.
Insomnia in Late Pregnancy Associated With Perinatal Anxiety
Gestational insomnia is associated with anxiety symptoms, both during pregnancy and after childbirth.
OnabotulinumtoxinA Effective in Reducing Depression and Anxiety Symptoms in Chronic Migraines
Patients with self-reported anxiety, depression, with or without chronic migraine, were found to have their symptoms alleviated with onabotulinumtoxinA.
Childhood Social-Emotional Functioning Linked To Early-Onset Mental Health Conditions
Researchers investigated early childhood social-emotional functioning and mental health condition development.
eHealth Interventions Beneficial for Reducing Perinatal Anxiety
Compared with controls, eHealth interventions were found to be associated with significantly lower anxiety scores for women during the perinatal period.
Chronic Rhinosinusitis Linked to Depression, Anxiety
Chronic rhinosinusitis (CRS) is associated with incidence of depression and anxiety.
Benzodiazepines and Related Drugs Associated With Increased Pneumonia Risk
Current or recent exposure to benzodiazepines and related drugs may increase the risk for pneumonia.
Shortage of Buspirone Concerns Patients and Clinicians
A shortage of the anti-anxiety drug buspirone in the United States has patients and doctors concerned.
Next post in Anxiety
